Table 1 Baseline demographic and clinical characteristics in overall cohort
From: Preoperative beta-blocker in ventricular dysfunction patients: need a more granular quality metric
Variables | All patient (n = 6116) | Beta-blocker use groups | P | |
|---|---|---|---|---|
No (n = 2343) | Yes (n = 3773) | |||
Age, mean (SD), years | 61.3 (9.2) | 61.4 (9.3) | 61.3 (9.1) | 0.921 |
Female, n (%) | 988 (16.2) | 402 (17.2) | 586 (15.5) | 0.093 |
BMI, mean (SD) | 24.7 (3.2) | 24.7 (3.1) | 24.8 (3.2) | 0.445 |
Smoking history, n (%) | 3388 (55.4) | 1304 (55.7) | 2084 (55.2) | 0.748 |
Diabetes mellitus, n (%) | 2079 (34.0) | 757 (32.3) | 1322 (35.0) | 0.028 |
Hypertension, n (%) | 3353 (54.8) | 1237 (52.8) | 2116 (56.1) | 0.012 |
Hyperlipemia, n (%) | 1970 (32.2) | 816 (34.8) | 1154 (30.6) | 0.001 |
Chronic renal failure, n (%) | 113 (1.8) | 37 (1.6) | 76 (2.0) | 0.219 |
COPD, n (%) | 94 (1.5) | 46 (2.0) | 48 (1.3) | 0.033 |
Peripheral artery disease, n (%) | 260 (4.3) | 103 (4.4) | 157 (4.2) | 0.658 |
Carotid disease, n (%) | 1000 (16.4) | 441 (18.8) | 559 (14.8) | < 0.001 |
Cerebrovascular accident, n (%) | 527 (8.6) | 191 (8.2) | 336 (8.9) | 0.307 |
Creatinine, median (25th, 75th percentile), umol/dL | 82.0 (70.0,96.6) | 81.7 (69.0,95.9) | 44.0 (40,46) | 0.132 |
Left main CAD, n (%) | 1625 (26.6) | 589 (25.1) | 1036 (27.5) | 0.046 |
Triple vessel disease, n (%) | 4218 (69.0) | 2275 (73.5) | 1443 (61.6) | < 0.001 |
Previous MI, n (%) | 2561 (41.9) | 952 (40.6) | 1609 (42.6) | 0.121 |
PTCA history, n (%) | 760 (12.4) | 255 (10.9) | 505 (13.4) | 0.004 |
CCS class | < 0.001 | |||
NA, n (%) | 1181 (19.3) | 508 (21.7) | 673 (17.8) | |
I, n (%) | 886 (14.5) | 348 (14.9) | 216 (5.7) | |
II, n (%) | 2086 (34.1) | 666 (28.4) | 926 (24.5) | |
III, n (%) | 1606 (26.3) | 680 (29.0) | 1420 (37.5) | |
IV, n (%) | 357 (5.8) | 141 (6.0) | 538 (14.3) | |
LVEF, Mean (SD), % | 42.3 (5.2) | 42.3 (5.1) | 42.3 (5.3) | 0.484 |
LVEDD, Median (25th, 75th percentile), mm | 49 (55, 60) | 55 (47, 60) | 56 (50,60) | 0.002 |
NYHA class | < 0.001 | |||
I, n (%) | 865 (14.1) | 257 (11.0) | 608 (16.1) | |
II, n (%) | 2252 (36.8) | 864 (36.9) | 1388 (36.8) | |
III, n (%) | 2694 (44.0) | 1091 (46.6) | 1603 (42.5) | |
IV, n (%) | 305 (5.0) | 131 (5.6) | 174 (4.6) | |
Atrial fibrillation, n (%) | 123 (2.0) | 44 (1.9) | 79 (2.1) | 0.559 |
Prior cardiovascular surgery, n (%) | 69 (1.1) | 23 (1.0) | 46 (1.2) | 0.393 |
Preoperative ACEI/ARB, n(%) | 1951 (29.9) | 535 (21.3) | 1416 (35.3) | < 0.001 |
STS PROM, Median (25th, 75th percentile),% | 3.0 [2.1, 4.4] | 2.9 [2.0, 4.3] | 3.1 [2.2, 4.6] | < 0.001 |